Yifeng Pharmacy Stock Beneish M Score

603939 Stock   22.56  1.40  5.84%   
This module uses fundamental data of Yifeng Pharmacy to approximate the value of its Beneish M Score. Yifeng Pharmacy M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Yifeng Pharmacy. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
  
The current year's Short and Long Term Debt is expected to grow to about 459.2 M, whereas Long Term Debt is forecasted to decline to about 126.9 M.
At this time, Yifeng Pharmacy's M Score is inapplicable. The earnings manipulation may begin if Yifeng Pharmacy's top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Yifeng Pharmacy executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Yifeng Pharmacy's earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-3.32
Beneish M Score - Inapplicable
Elasticity of Receivables

1.0

Focus
Asset Quality

1.57

Focus
Expense Coverage

1.0

Focus
Gross Margin Strengs

N/A

Focus
Accruals Factor

1.0

Focus
Depreciation Resistance

N/A

Focus
Net Sales Growth

1.05

Focus
Financial Leverage Condition

1.0

Focus

Yifeng Pharmacy Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Yifeng Pharmacy's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Net Receivables2.2 B2.1 B
Sufficiently Up
Slightly volatile
Total Revenue23.7 B22.6 B
Sufficiently Up
Slightly volatile
Total Assets25.3 B24.1 B
Sufficiently Up
Slightly volatile
Total Current Assets6.8 B12.1 B
Way Down
Slightly volatile
Non Current Assets Total6.4 B12 B
Way Down
Slightly volatile
Property Plant Equipment5.9 B5.6 B
Sufficiently Up
Slightly volatile
Selling General Administrative5.9 B5.6 B
Sufficiently Up
Slightly volatile
Total Current Liabilities11.8 B11.3 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total1.5 B2.4 B
Way Down
Slightly volatile
Short Term Debt18.9 M33.7 M
Way Down
Slightly volatile
Long Term Debt126.9 M133.6 M
Notably Down
Slightly volatile
Operating Income2.2 B2.1 B
Sufficiently Up
Slightly volatile
Total Cash From Operating Activities4.9 B4.6 B
Sufficiently Up
Slightly volatile
Short Term Investments1.7 B1.6 B
Sufficiently Up
Slightly volatile
Long Term Investments25.3 M34 M
Way Down
Slightly volatile

Yifeng Pharmacy Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Yifeng Pharmacy's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Yifeng Pharmacy in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Yifeng Pharmacy's degree of accounting gimmicks and manipulations.

About Yifeng Pharmacy Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Reconciled Depreciation

1.73 Billion

At present, Yifeng Pharmacy's Reconciled Depreciation is projected to increase significantly based on the last few years of reporting.

Yifeng Pharmacy Earnings Manipulation Drivers

Although earnings manipulation is typically not the result of intentional misconduct by the c-level executives, it is still a widespread practice by the senior management of public companies such as Yifeng Pharmacy. It is usually done by a series of misrepresentations of various accounting rules and operating activities across multiple financial cycles. The best way to spot the manipulation is to examine the historical financial statement to find inconsistencies in earning reports to find trends in assets or liabilities that are not sustainable in the future.
201920202021202220232024 (projected)
Net Receivables953.0M830.3M1.1B1.8B2.1B2.2B
Total Revenue10.3B13.1B15.3B19.9B22.6B23.7B
Total Assets9.2B12.9B17.1B21.0B24.1B25.3B
Total Current Assets5.0B7.7B7.9B10.6B12.1B6.8B
Non Current Assets Total4.2B4.9B9.1B10.5B12.0B6.4B
Property Plant Equipment528.0M3.6B4.5B4.9B5.6B5.9B
Selling General Administrative2.7B3.3B4.1B5.0B5.6B5.9B
Total Current Liabilities3.7B5.9B6.7B9.7B11.3B11.8B
Non Current Liabilities Total741.3M2.0B2.4B2.3B2.4B1.5B
Long Term Debt687.2M2.0B365.6M228.7M133.6M126.9M
Operating Income840.4M1.2B1.5B2.0B2.1B2.2B
Total Cash From Operating Activities963.2M2.3B2.1B3.9B4.6B4.9B
Investments53.0M(531.0M)681.0M(241.0M)(3.0B)(2.8B)
Short Term Investments193.2M744.8M152.2M50.0M1.6B1.7B

About Yifeng Pharmacy Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Yifeng Pharmacy's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Yifeng Pharmacy using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Yifeng Pharmacy based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Yifeng Stock

Yifeng Pharmacy financial ratios help investors to determine whether Yifeng Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Yifeng with respect to the benefits of owning Yifeng Pharmacy security.